JohnAKostevaMD

PubMed

• Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidat...
  Barsouk, A., Friedes, C., Iocolano, M., Doucette, A., Cohen, R., Robinson, K., D'Avella, C., Marmarelis, M., Kosteva, J., Singh, A., Ciunci, C., Levin, W., Cengel, K.,...> ;Clinical Lung Cancer. 2023 Dec 22
• 4 citations
  Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.
  Charu Aggarwal, Melina E Marmarelis, Wei-Ting Hwang, Dylan G Scholes, Tara L McWilliams, Aditi P Singh, Lova Sun, John Kosteva, Michael R Costello, Roger B Cohen, Core...> ;JCO Precision Oncology. 2023 Jul 1
• 1 citations
  Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System.
  Nikhil Yegya-Raman, Cole Friedes, Lova Sun, Michelle Iocolano, Kristine N Kim, Abigail Doucette, Roger B Cohen, Kyle W Robinson, William P Levin, Keith A Cengel, Brian...> ;Clinical Lung Cancer. 2023 Jul 1
• 366 citations
  Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer.
  Stephen J Bagley, Shawn Kothari, Charu Aggarwal, Joshua Bauml, Evan W. Alley, Tracey L. Evans, John A. Kosteva, Christine Ciunci, Peter Gabriel, Jeffrey C. Thompson, S...> ;Lung Cancer. 2017 Apr 1
• 233 citations
  Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA
  Jeffrey C. Thompson, Stephanie S. Yee, Andrea B. Troxel, Samantha L. Savitch, Ryan Fan, David Balli, David B. Lieberman, Jennifer J.D. Morrissette, Tracey L. Evans, Jo...> ;Clinical Cancer Research. 2016 Dec 1
• 25 citations
  The changing landscape of the medical management of skeletal metastases in nonsmall cell lung cancer
  John Kosteva, Corey J. Langer> ;Current Opinion in Oncology. 2008 Mar 1
• Join now to see all